Approaching the clinical application of xenotransplantation

American Journal of the Medical Sciences

Volumn 313, Issue 5, 1997, Pages 315-321

  Platt, Jeffrey L ^a,b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Graft rejection; Organ failure; Xenotransplantation; Zoonosis

Indexed keywords

ARTICLE; CELLULAR IMMUNITY; COMPLEMENT ACTIVATION; GENETIC ENGINEERING; GRAFT REJECTION; HUMAN; HUMORAL IMMUNITY; INFECTION RISK; NONHUMAN; XENOTRANSPLANTATION; ZOONOSIS;

EID: 0030961725     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9629(15)40123-5     Document Type: Article

References (59)

1. Evans RW, Orians CE, Ascher NL. The potential supply of organ donors: An assessment of the efficiency of organ procurement efforts in the United States. JAMA. 1992; 267:239-46.
2. Starzl TE, Fung J, Tzakis A, Todo S, Demetris AJ, Marlao IR, et al. Baboon-to-human liver transplantation. Lancet. 1993;341:65-71.
3. Platt JL, Logan JS. Use of transgenic animals in xenotransplantation. Transplantation Reviews. 1996;10:69-77.
4. Sun Y, Xiaojun M, Zhou D, Vacek I, Sun AM. Normalization of diabetes in spontaneously diabetic cynomolgus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J Clin Invest. 1996, In Press.
5. Ricordi C, Lacy PE, Sterbenz K, Davie JM. Low-temperature culture of human islets or in vivo treatment with L3T4 antibody produces a marked prolongation of islet human-to-mouse xenograft survival. Proc Natl Acad Sci U S A. 1987; 84:8080-4.
6. Platt JL. The immunological barriers to xenotransplantation. Crit Rev Immunology. In Press.
7. Parker W, Saadi S, Lin SS, Holzknecht ZE, Bustos M, Platt JL. Transplantation of discordant xenografts: A challenge revisited. Immunol Today. 1996;17:373-8.
8. Platt JL. Xenotransplantation: Recent progress and current perspective. Curr Opin Immunol. 1996, In Press.
9. Platt JL, Vercellotti GM, Dalmasso AP, et al. Transplantation of discordant xenografts: A review of progress. Immunol Today. 1990;11:450-6.
10. Platt JL, Fischel RJ, Matas AJ, Reif SA, Bolman RM, Bach FH. Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation. 1991; 52:214-20.
11. Dalmasso AP, Vercellotti GM, Fischel RJ, Bolman RM, Bach FH, Platt JL. Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. Am J Pathol. 1992;140:1157-66.
12. Good AH, Cooper DKC, Malcolm AJ, et al. Identification of carbohydrate structures that bind human antiporcine antibodies: Implications for discordant xenografting in humans. Transpl Proc. 1992;24:559-62.
13. Sandrin MS, Vaughan HA, Dabkowski PL, McKenzie IFC. Anti-pig IgM antibodies in human serum react predominantly with Gala(1,3)Gal epitopes. Proc Natl Acad Sci U S A. 1993;90:11391-5.
14. Collins BH, Parker WR, Platt JL. Characterization of porcine endothelial cell determinants recognized by human natural antibodies. Xenotransplantation. 1994;1:36-46.
15. Galili U, Macher BA, Buehler J, Shohet SB. Human natural anti-a-galactosyl IgG: The specific recognition of a(1-3)-linked glactose residues. J Exp Med. 1985;162:573-82.
16. Galili U, Clark MR, Shohet SB, Buchler J, Macher BA. Evolutionary relationship between the natural anti-Gal antibody and the Gal a1-3Gal epitope in primates. Proc Natl Acad Sci U S A 1987;84:1369-73.
17. Holzknecht ZE, Platt JL. Identification of porcine endothelial cell membrane antigens recognized by human xenoreactive antibodies. J Immunol. 1995;154:4565-75.
18. Auchincloss H Jr. Xenogeneic transplantation. Transplantation. 1988;46:1-20.
19. Chartrand C, O'Regan S, Robitaille P, Pinto-Blonde M. Delayed rejection of cardiac xenografts in Co-deficient rabbits. J Immunol. 1979;38:245.
20. Brauer RB, Baldwin WM III, Daha MR, Pruitt SK, Sanfilippo F. Use of C6-deficient rats to evaluate the mechanism of hyperacute rejection of discordant cardiac xenografts. J Immunol. 1993;151:7240-8.
21. Kroshus TJ, Rollins SA, Dalmasso AP, et al. Complement inhibition with an anti-C5 monoclonal antibody prevents acute cardiac tissue injury in an ex vivo model of pig-to- human xenotransplantation. Transplantation. 1995;60: 1194-1202.
22. Saadi S, Platt JL. Transient perturbation of endothelial integrity induced by antibodies and complement. J Exp Med. 1995;181:21-31.
23. Platt JL, Vercellotti GM, Lindman BJ, Oegema TR Jr, Bach FH, Dalmasso AP. Release of heparan sulfate from endothelial cells: Implications for pathogenesis of hyperacute rejection. J Exp Med. 1990;171:1363-8.
24. Ihrcke NS, Platt JL. Shedding of heparan sulfate proteoglycan by stimulated endothelial cells: Evidence for proteolysis of cell surface molecules. J Cell Physiol. 1996;168:625-37.
25. Saadi S, Ihrcke NS, Platt JL. Pathophysiology of xenograft rejection. In: Lieberman R, Morris R, eds. Principles of Immunomodulatory Drug Development in Transplantation and Autoimmunity. New York: Raven Press; 1996;31-45.
26. Dalmasso AP, Vercellotti GM, Platt JL, Bach FH. Inhibition of complement-mediated endothelial cell cytotoxicity by decay accelerating factor: Potential for prevention of xenograft hyperacute rejection. Transplantation. 1991;52:530-3.
27. McCurry KR, Kooyman DL, Alvarado CG, et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nature Medicine. 1995;1:423-7.
28. Byrne GW, McCurry KR, Martin MJ, McClellan SM, Platt JL, Logan JS. Expression of human CD59 and DAF in transgenic pigs: Intrinsic regulation of complement activity. Transplantation. 1997;63:149-55.
29. Gewurz H, Clark DS, Cooper MD, Varco RL, Good RA. Effect of cobra venom-induced inhibition of complement activity on allograft and xenograft rejection reactions. Transplantation. 1967;5:1296-1303.
30. Leventhal JR, Dalmasso AP, Cromwell JW, et al. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation. 1993;55:857-66.
31. Magee JC, Collins BH, Harland RC, et al. Immunoglobulin prevents complement mediated hyperacute rejection in swine-to-primate xenotransplantation. J Clin Invest. 1995; 96:2404-12.
32. Pruitt SK, Kirk AD, Bollinger RR, et al. The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation. 1994;57:363-70.
33. Perper RJ, Najarian JS. Experimental renal heterotransplantation. I. In widely divergent species. Transplantation. 1966;4:377-88.
34. Giles GR, Boehmig HJ, Lilly J, et al. Mechanism and modification of rejection of heterografts between divergent species. Transpl Proc. 1970;2:522-37.
35. Cooper DKC, Human PA, Lexer G, et al. Effects of cyclosporine and antibody adsorption on pig cardiac xenograft survival in the baboon. Journal of Heart Transplantation. 1988;7:238-46.
36. Fischel RJ, Matas AJ, Platt JL, et al. Cardiac xenografting in the pig to rhesus model; manipulation of anti-endothelial antibody prolongs survival. J Heart Lung Transplant. 1992;11:965-74.
37. Chopek MW, Simmons RL, Platt JL. ABO incompatible renal transplantation: Initial immunopathologic evaluation. Transpl Proc. 1987;19:4553-7.
38. Leventhal JR, Matas AJ, Sun LH, et al. The immunopathology of cardiac xenograft rejection in the guinea pig to rat model. Transplantation. 1993;56:1-8.
39. Cotterell AH, Collins BH, Parker W, Harland RC, Platt JL. The humoral immune response in humans following cross-perfusion of porcine organs. Transplantation. 1995; 60:861-8.
40. Saadi S, Holzkhecht RA, Patte CP, Stern DM, Platt JL. Complement-mediated regulation of tissue factor activity in endothelium. J Exp Med. 1995;182:1807-14.
41. Geller RL, Rubinstein P, Platt JL. Variation in expression of xenoreactive antigens on porcine platelets. Transplantation. 1994;58:272-7.
42. Alvarado CG, Cotterell AH, McCurry KR, et al. Variation in the level of xenoantigen expression in porcine organs. Transplantation. 1995;59:1589-96.
43. Sandrin MS, Fodor WL, Mouhtouris E, et al. Enzymatic remodelling of the carbohydrate surface of a xenogeneic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nature Medicine. 1995;1:1261-7.
44. Sharma A, Okabe JF, Birch P, Platt JL, Logan JS. Reduction in the level of gal (a1,3) gal in transgenic mice and pigs by the expression of an a(1,2) fucosyltransferase. Proc Natl Acad Sci U S A. 1996;93:7190-5.
45. Alter BJ, Bach FH. Cellular basis of the proliferative response of human T cells to mouse xenoantigens. J Exp Med. 1990;191:333-8.
46. Murray AG, Khodadoust MM, Pober JS, Bothwell ALM. Porcine aortic endothelial cells activate human T cells: Direct presentation of MHC antigens and costimulation by ligands for human CD2 and CD28. Immunity. 1994;1:57-63.
47. Dahlback B, Hildebrand B. Inherited resistance to activated protein c is corrected by anticoagulant cofactor activity found to be a property of factor v. Proc Natl Acad Sci U S A. 1994;91:1396-1400.
48. Kirk AD, Li RA, Kinch S, et al. The human antiporcine cellular repertoire. In vitro studies of acquired and innate cellular responsiveness. Transplantation. 1993;55:924.
49. Yamada K, Sachs DH, DerSimonian H. Human anti-porcine xenogeneic T cell response. Evidence for allelic specificity of mixed leukocyte reaction and for both direct and indirect pathways of recognition. J Immunol. 1995;155:5249-56.
50. Alexandre GPJ, Gianello P, Latinne D, et al. Plasmapheresis and splenectomy in experimental renal xenotransplantation. In: Hardy, MA, ed. Xenograft 25. New York: Elsevier Science Publishers: 1989:259-66.
51. Sachs DH, Sablinski T. Tolerance across discordant xenogeneic barriers. Xenotransplantation. 1995;2:234-9.
52. Harland RC and Platt JL. Prospects for xenotransplantation of the liver. J Hepatology. In Press.
53. Chari RS, Collins BH, Magee JC, et al. Treatment of hepatic failure with ex-vivo pig liver perfusion followed by liver transplantation. N Eng J Med. 1994;331:234-7.
54. Calne RY, White HJO, Herbertson BM, et al. Pig-to-baboon liver xenografts. Lancet. 1968;1:1176-8.
55. Lawson JH, Platt JL. Molecular barriers to xenotransplantation. Transplantation. 1996;62:303-10.
56. Lawson JH, Daniels L, Platt JL. The evaluation of thrombomodulin activity in porcine to human Xenotransplantation. Transplant Proc. 1997. In Press.
57. Michaels MG, Sinimons RL. Xenotransplant-associated zoonoses. Transplantation. 1994;57:1-7.
58. Ye Y, Niekrasz M, Kosanke S, et al. The pig as a potential organ donor for man. Transplantation. 1994;57:694-703.
59. Chapman LE, Folks TM, Salomon DR, Patterson AP, Eggerman TE and Noguchi PD. Xenotransplantation and xenogeneic infections. N Eng J Med. 1995;333:1498-1501.